Practices in the United States and Canada using AviClear will now have access to more perks. Cutera announced that it will be launching a rewards program for AviClear practices designed to reinforce a partnership approach with practices with improved profitability, enhanced marketing support, and increased access to patient demand.
“The program will recognize practices with steady treatment volume through forward-looking revenue fee discounts, placing more profits in the pockets of practitioners. Program advantages include cooperative advertising dollars that can be reinvested into the partnership, cross-portfolio incentives to partner with additional technology, and specialized perks associated with different performance tiers,” Cutera stated in a company news release.
Cutera received FDA clearance for AviClear in March 2022 as the only FDA cleared energy device for the treatment of mild to severe acne.
AviClear is now available to physicians and practitioners across the United States and Canada.
